Back
Day Range
$10.88
$11.04
52-Week Range
$5.30
$14.85
Volume
81,269
50D / 200D Avg
$12.40
/
$9.41
Prev Close
$10.90
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -12.4 | 0.2 |
| P/B | 1.7 | 3.0 |
| ROE % | -12.0 | 3.6 |
| Net Margin % | -7.9 | 3.8 |
| Rev Growth 5Y % | -0.2 | 9.9 |
| D/E | 1.4 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$1.45
$1.42 – $1.49
|
49.66B | 1 |
| FY2028 |
$1.27
$1.25 – $1.31
|
48.30B | 1 |
| FY2027 |
$1.18
$1.10 – $1.26
|
46.66B | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-04 | $0.10 | $0.18 | +86.3% |
| 2025-11-12 | $0.13 | $0.17 | +30.8% |
| 2025-08-06 | $0.25 | $0.35 | +40.0% |
| 2025-03-05 | $0.28 | $0.28 | 0.0% |
| 2024-12-31 | N/A | -$0.09 | — |
| 2024-11-12 | $0.17 | $0.07 | -58.8% |
| 2024-08-06 | $0.25 | $0.25 | 0.0% |
| 2024-05-14 | $0.46 | $0.77 | +68.9% |
Dividend History
7 yr streakYield
0.00%
Payout Ratio
-0.04%
Growth (3Y)
-61.02%
Growth (5Y)
-47.25%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 29, 2025 | May 12, 2025 | $0.03 | 0.47% |
| Apr 29, 2024 | May 13, 2024 | $0.03 | 0.40% |
| May 02, 2023 | May 15, 2023 | $0.66 | 4.18% |
| May 02, 2022 | May 16, 2022 | $0.53 | 3.33% |
| Apr 28, 2021 | May 10, 2021 | $0.60 | 3.71% |
| Apr 29, 2020 | May 14, 2020 | $0.76 | 4.56% |
| Apr 29, 2019 | May 13, 2019 | $0.78 | 7.14% |
| Jun 22, 2018 | Jul 02, 2018 | $0.42 | 4.24% |
| May 25, 2018 | Jun 11, 2018 | $0.81 | 2.76% |
| May 01, 2017 | May 15, 2017 | $2.96 | 2.42% |
| Apr 27, 2016 | May 12, 2016 | $2.87 | 2.42% |
| May 22, 2015 | Jun 08, 2015 | $2.46 | 1.65% |
| Apr 25, 2014 | May 12, 2014 | $2.90 | 2.23% |
| Apr 24, 2013 | May 09, 2013 | $2.48 | 2.41% |
| Apr 25, 2012 | May 10, 2012 | $2.15 | 3.14% |
| Apr 27, 2011 | May 12, 2011 | $2.21 | 2.66% |
| Apr 28, 2010 | May 13, 2010 | $1.84 | 2.87% |
| May 08, 2009 | May 26, 2009 | $1.89 | 3.77% |
| Apr 23, 2008 | May 08, 2008 | $2.10 | 2.57% |
| Apr 25, 2007 | May 10, 2007 | $1.36 | 1.99% |
Key Takeaways
Revenue declined -0.17% annually over 5 years
Generating 2.00B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.90%
Capital efficient — spends only 5.46% of revenue on capex
Growth
Revenue Growth (5Y)
-0.17%
Revenue (1Y)-6.07%
Earnings (1Y)N/A
FCF Growth (3Y)-8.02%
Quality
Return on Equity
-12.02%
ROIC7.91%
Net Margin-7.94%
Op. Margin15.26%
Safety
Debt / Equity
1.44
Current Ratio1.00
Interest Coverage4.04
Valuation
P/E Ratio
-12.41
Forward P/E10.00
P/B Ratio1.66
EV/EBITDA11.06
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.07% | Revenue Growth (3Y) | -4.14% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0.17% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 43.78B | Net Income (TTM) | -3.48B |
| ROE | -12.02% | ROA | -3.15% |
| Gross Margin | 59.21% | Operating Margin | 15.26% |
| Net Margin | -7.94% | Free Cash Flow (TTM) | 2.00B |
| ROIC | 7.91% | FCF Growth (3Y) | -8.02% |
| Safety | |||
| Debt / Equity | 1.44 | Current Ratio | 1.00 |
| Interest Coverage | 4.04 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | -0.04% |
| Dividend Growth (3Y) | -61.02% | Dividend Growth (5Y) | -47.25% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | -12.41 | Forward P/E | 10.00 |
| P/B Ratio | 1.66 | P/S Ratio | 0.99 |
| PEG Ratio | -0.29 | Forward PEG | N/A |
| EV/EBITDA | 11.06 | Fwd EV/EBITDA | 5.24 |
| Forward P/S | 0.95 | Fwd Earnings Yield | 10.00% |
| FCF Yield | 4.64% | ||
| Market Cap | 43.15B | Enterprise Value | 73.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43.78B | 46.61B | 47.64B | 50.74B | 44.08B |
| Net Income | -3.48B | -2.55B | -2.94B | 4.15B | 1.00B |
| EPS (Diluted) | -0.88 | -0.65 | -0.75 | 1.06 | 0.26 |
| Gross Profit | 25.92B | 25.34B | 27.89B | 30.87B | 27.27B |
| Operating Income | 6.68B | 3.33B | -150.00M | 6.26B | 6.98B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 110.56B | 110.85B | 116.26B | 124.88B | 120.24B |
| Total Liabilities | 84.51B | 78.81B | 83.18B | 85.95B | 87.07B |
| Shareholders' Equity | 25.94B | 31.91B | 32.93B | 38.77B | 33.02B |
| Total Debt | 37.43B | 40.70B | 44.79B | 41.65B | 39.53B |
| Cash & Equivalents | 6.67B | 6.19B | 5.91B | 5.17B | 4.56B |
| Current Assets | 32.43B | 34.44B | 37.56B | 37.76B | 32.58B |
| Current Liabilities | 32.57B | 28.95B | 29.46B | 35.08B | 29.40B |